NCT06096558View on ClinicalTrials.gov

The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

January 20, 2024

Study Completion Date

May 1, 2024

Conditions
Peritoneal Dialysis
Interventions
DIETARY_SUPPLEMENT

Melatonin

5 mg Melatonin in one tablet, 30 minutes before night sleep

OTHER

placebo

1 tablet of placebo (starch)

All Listed Sponsors
lead

National Nutrition and Food Technology Institute

OTHER

NCT06096558 - The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients | Biotech Hunter | Biotech Hunter